Susquehanna International Group, LLP Rocket Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 48,035 shares of RCKT stock, worth $535,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,035

Previous 50,497 4.88%

Holding current value

$535,109

Previous $1.09 Million 18.4%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $43,331 - $63,716	-2,462 Reduced 4.88%	48,035 $887,000
Q2 2024 Aug 15, 2024	SELL	$20.66 - $26.72 $46,464 - $60,093	-2,249 Reduced 4.26%	50,497 $1.09 Million
Q1 2024 May 07, 2024	BUY	$26.16 - $30.74 $368,332 - $432,819	14,080 Added 36.41%	52,746 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $211,310 - $402,220	12,593 Added 48.3%	38,666 $1.16 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $118,088 - $188,455	-7,836 Reduced 23.11%	26,073 $534,000
Q2 2023 Aug 11, 2023	SELL	$16.59 - $23.6 $1.38 Million - $1.96 Million	-83,009 Reduced 71.0%	33,909 $673,000
Q1 2023 May 16, 2023	BUY	$15.79 - $22.6 $1.1 Million - $1.58 Million	69,841 Added 148.35%	116,918 $2 Million
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $438,092 - $643,288	-28,264 Reduced 37.51%	47,077 $921,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $617,102 - $918,419	49,887 Added 195.99%	75,341 $1.2 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $240,710 - $503,193	-30,240 Reduced 54.3%	25,454 $350,000
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $122,032 - $219,584	-9,273 Reduced 14.27%	55,694 $883,000
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $665,506 - $1.11 Million	-30,925 Reduced 32.25%	64,967 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $415,385 - $741,846	15,149 Added 18.76%	95,892 $2.87 Million
Q2 2021 Aug 11, 2021	SELL	$39.41 - $47.25 $3.12 Million - $3.74 Million	-79,241 Reduced 49.53%	80,743 $3.58 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $2.57 Million - $3.91 Million	59,387 Added 59.03%	159,984 $7.1 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $2.04 Million - $5.22 Million	87,545 Added 670.74%	100,597 $5.52 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $318,549 - $444,260	-15,539 Reduced 54.35%	13,052 $298,000
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $73,456 - $189,957	7,565 Added 35.98%	28,591 $399,000
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $515,429 - $702,123	-47,505 Reduced 69.32%	21,026 $245,000
Q2 2019 Aug 16, 2019	BUY	$15.0 - $19.81 $38,295 - $50,574	2,553 Added 3.87%	68,531 $1.03 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $989,670 - $1.31 Million	65,978 New	65,978 $990,000

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $843M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Rocket Pharmaceuticals, Inc. Transaction History